サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1298234

ゲノミクスにおけるAI市場：オファリング別、技術別、アプリケーション別、エンドユーザー別：世界の機会分析と産業予測、2021-2031年

AI in Genomics Market By Offering, By Technology, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 420 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ゲノミクスにおけるAI市場：オファリング別、技術別、アプリケーション別、エンドユーザー別：世界の機会分析と産業予測、2021-2031年
出版日: 2023年03月01日
発行: Allied Market Research
ページ情報: 英文 420 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゲノミクスにおけるAIの世界市場は、2021年に3億4,000万米ドルと評価され、2022年から2031年にかけてCAGR 40.6%で成長し、2031年には99億米ドルに達すると予測されています。

ゲノミクスは、生物の遺伝物質（DNA）全体の研究に焦点を当てた分子生物学の一分野です。ゲノムの構造、機能、進化を解析し、遺伝子、その制御エレメント、それらがどのように相互作用しているかを明らかにします。ゲノミクスの分野は、DNAの塩基配列をより迅速かつ正確に解析できるようになった技術の進歩により、ここ数十年で急速に発展してきました。ハイスループット・シーケンス技術の出現により、以前必要とされていたコストと時間の何分の一かでゲノム全体の塩基配列を決定することが可能になっています。ゲノミクスにおけるAI市場とは、ゲノム研究やアプリケーションをサポートするための人工知能（AI）技術の使用を指します。膨大な量のゲノムデータが生成される中、このデータを分析・解釈するためのAIツールの重要性が増しています。

AI in Genomics Market-IMG1

ゲノミクスにおけるAI市場の促進要因は、AI技術の進歩、個別化医療に対する需要の増加、研究およびヘルスケアにおけるゲノミクスの導入の増加、ゲノミクスにおけるAIへの投資の増加です。AI技術の進歩は、機械学習、自然言語処理、ディープラーニングの研究開発の結果であり、研究者はゲノムデータをより正確かつ効率的に分析・解釈できるようになっています。AI技術の改良が進むにつれ、ゲノミクスへの応用はさらに広まると予想されます。個別化医療では、ゲノムデータに基づいて個々の患者に合わせた治療計画を立てる。個別化医療の需要が拡大し続ける中、患者の疾患や状態に関連する可能性のある遺伝的変異を特定するために、ゲノミクスにおけるAIツールの利用はますます重要になっています。例えば、国立医学図書館による2022年の報告書によると、アルツハイマー病に加えて、炎症性疾患である関節リウマチと乾癬は、疾患メカニズム、診断バイオマーカー、診断マーカーを用いた治療薬、治療満足度の観点から、個別化医療に対するアンメットニーズが高い疾患です。

さらに、ゲノミクスは、疾患やその他の症状の遺伝的基盤に関する重要な洞察を提供するため、研究とヘルスケアの両面でますます重要なツールとなっています。このため、ゲノム・データを解析・解釈するための、より高度なAIツールや技術が求められています。しかし、高コストのデータ品質問題や熟練した専門家の限られた利用可能性などの要因が、ゲノミクスにおけるAI市場の成長を抑制すると予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資ポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競合の激しさ
  • 市場力学
    • 促進要因
      • AI技術の進歩
      • 研究およびヘルスケアにおけるゲノミクス導入の増加
      • 個別化医療に対する需要の増加
    • 抑制要因
      • 熟練した専門家の不足
      • データ品質の問題
    • 機会
      • 人間を意識したAIの開発
  • COVID-19による市場への影響分析

第4章 ゲノミクスにおけるAI市場：オファリング別

  • 概要
    • 市場規模と予測
  • ハードウェア
    • 主な市場動向、成長要因、成長機会
    • 市場規模・予測： 地域別
    • 市場シェア分析：国別
  • ソフトウェア
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • サービス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析： 国別

第5章 ゲノミクスにおけるAI市場：技術別

  • 概要
    • 市場規模・予測
  • 機械学習
    • 主要市場動向、成長要因、成長機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • コンピュータビジョン
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析： 国別

第6章 ゲノミクスにおけるAI市場：アプリケーション別

  • 概要
    • 市場規模と予測
  • 創薬と医薬品開発
    • 主要市場動向、成長要因、成長機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 精密医療
    • 主要市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 診断薬
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第7章 ゲノミクスにおけるAI市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 製薬・バイオ企業
    • 主要市場動向、成長要因、成長機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • ヘルスケアプロバイダー
    • 主要市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 研究センター
    • 主要市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析： 国別

第8章 ゲノミクスにおけるAI市場：地域別

  • 概要
    • 市場規模・予測： 地域別
  • 北米
    • 主要動向と機会
    • 市場規模・予測：オファリング別
    • 市場規模・予測：技術別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 米国
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • カナダ
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • メキシコ
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • 欧州
    • 主要動向と機会
    • 市場規模・予測：オファリング別
    • 市場規模・予測：技術別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ドイツ
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • フランス
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 英国
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • イタリア
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • スペイン
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • その他欧州
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • アジア太平洋地域
    • 主な動向と機会
    • 市場規模・予測：オファリング別
    • 市場規模・予測：技術別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 日本
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 中国
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • オーストラリア
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • インド市場
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 韓国市場
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • ラテンアメリカ・中東・アフリカ
    • 主要動向と機会
    • 市場規模・予測：オファリング別
    • 市場規模・予測：技術別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ブラジル
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • サウジアラビア
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 南アフリカ
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • その他の地域
      • 主要市場動向、成長要因、成長機会
      • 市場規模・予測：オファリング別
      • 市場規模・予測：技術別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別

第9章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2021年

第10章 企業プロファイル

  • Microsoft Corporation
  • IBM Corporation
  • NVIDIA Corporation（Mellanox Technologies）
  • Deep Genomics
  • Data4Cure, Inc
  • Freenome Holdings, Inc
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Sophia Genetics
  • BenevolentAI
図表

LIST OF TABLES

  • TABLE 01. GLOBAL AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 02. AI IN GENOMICS MARKET FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. AI IN GENOMICS MARKET FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. AI IN GENOMICS MARKET FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. GLOBAL AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 06. AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. AI IN GENOMICS MARKET FOR COMPUTER VISION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. GLOBAL AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 09. AI IN GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. AI IN GENOMICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. GLOBAL AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 14. AI IN GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. AI IN GENOMICS MARKET FOR RESEARCH CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. AI IN GENOMICS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 21. NORTH AMERICA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 22. NORTH AMERICA AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. U.S. AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 24. U.S. AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 25. U.S. AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 26. U.S. AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 27. CANADA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 28. CANADA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 29. CANADA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 30. CANADA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. MEXICO AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 32. MEXICO AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 33. MEXICO AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. MEXICO AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. EUROPE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 36. EUROPE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 37. EUROPE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 40. GERMANY AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 41. GERMANY AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 42. GERMANY AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 43. GERMANY AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. FRANCE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 45. FRANCE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 46. FRANCE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. FRANCE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. UK AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 49. UK AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 50. UK AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. UK AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. ITALY AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 53. ITALY AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 54. ITALY AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 55. ITALY AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 56. SPAIN AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 57. SPAIN AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. REST OF EUROPE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 72. JAPAN AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 73. CHINA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 74. CHINA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 75. CHINA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. CHINA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. INDIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 82. INDIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 83. INDIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 84. INDIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. SOUTH KOREA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 86. SOUTH KOREA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 87. SOUTH KOREA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 88. SOUTH KOREA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. LAMEA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 97. LAMEA AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 98. BRAZIL AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 99. BRAZIL AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 100. BRAZIL AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 101. BRAZIL AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 102. SAUDI ARABIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 103. SAUDI ARABIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 104. SAUDI ARABIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 105. SAUDI ARABIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 106. SOUTH AFRICA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 107. SOUTH AFRICA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 108. SOUTH AFRICA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 109. SOUTH AFRICA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 110. REST OF LAMEA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
  • TABLE 111. REST OF LAMEA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 113. REST OF LAMEA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 114. MICROSOFT CORPORATION: KEY EXECUTIVES
  • TABLE 115. MICROSOFT CORPORATION: COMPANY SNAPSHOT
  • TABLE 116. MICROSOFT CORPORATION: SERVICE SEGMENTS
  • TABLE 117. MICROSOFT CORPORATION: PRODUCT PORTFOLIO
  • TABLE 118. MICROSOFT CORPORATION: KEY STRATERGIES
  • TABLE 119. IBM CORPORATION: KEY EXECUTIVES
  • TABLE 120. IBM CORPORATION: COMPANY SNAPSHOT
  • TABLE 121. IBM CORPORATION: SERVICE SEGMENTS
  • TABLE 122. IBM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 123. IBM CORPORATION: KEY STRATERGIES
  • TABLE 124. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): KEY EXECUTIVES
  • TABLE 125. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): COMPANY SNAPSHOT
  • TABLE 126. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): PRODUCT SEGMENTS
  • TABLE 127. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): PRODUCT PORTFOLIO
  • TABLE 128. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): KEY STRATERGIES
  • TABLE 129. DEEP GENOMICS: KEY EXECUTIVES
  • TABLE 130. DEEP GENOMICS: COMPANY SNAPSHOT
  • TABLE 131. DEEP GENOMICS: SERVICE SEGMENTS
  • TABLE 132. DEEP GENOMICS: PRODUCT PORTFOLIO
  • TABLE 133. DEEP GENOMICS: KEY STRATERGIES
  • TABLE 134. DATA4CURE, INC: KEY EXECUTIVES
  • TABLE 135. DATA4CURE, INC: COMPANY SNAPSHOT
  • TABLE 136. DATA4CURE, INC: SERVICE SEGMENTS
  • TABLE 137. DATA4CURE, INC: PRODUCT PORTFOLIO
  • TABLE 138. FREENOME HOLDINGS, INC: KEY EXECUTIVES
  • TABLE 139. FREENOME HOLDINGS, INC: COMPANY SNAPSHOT
  • TABLE 140. FREENOME HOLDINGS, INC: SERVICE SEGMENTS
  • TABLE 141. FREENOME HOLDINGS, INC: PRODUCT PORTFOLIO
  • TABLE 142. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 143. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 144. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
  • TABLE 145. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 146. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 147. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 148. ILLUMINA, INC.: PRODUCT SEGMENTS
  • TABLE 149. ILLUMINA, INC.: PRODUCT PORTFOLIO
  • TABLE 150. ILLUMINA, INC.: KEY STRATERGIES
  • TABLE 151. SOPHIA GENETICS: KEY EXECUTIVES
  • TABLE 152. SOPHIA GENETICS: COMPANY SNAPSHOT
  • TABLE 153. SOPHIA GENETICS: PRODUCT SEGMENTS
  • TABLE 154. SOPHIA GENETICS: SERVICE SEGMENTS
  • TABLE 155. SOPHIA GENETICS: PRODUCT PORTFOLIO
  • TABLE 156. BENEVOLENTAI: KEY EXECUTIVES
  • TABLE 157. BENEVOLENTAI: COMPANY SNAPSHOT
  • TABLE 158. BENEVOLENTAI: SERVICE SEGMENTS
  • TABLE 159. BENEVOLENTAI: PRODUCT PORTFOLIO
  • TABLE 160. BENEVOLENTAI: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. AI IN GENOMICS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF AI IN GENOMICS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN AI IN GENOMICS MARKET (2022-2031)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALAI IN GENOMICS MARKET
  • FIGURE 10. AI IN GENOMICS MARKET, BY OFFERING, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR HARDWARE, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR SOFTWARE, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR SERVICES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 14. AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR COMPUTER VISION, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 17. AI IN GENOMICS MARKET, BY APPLICATION, 2021(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 22. AI IN GENOMICS MARKET, BY END USER, 2021(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR RESEARCH CENTERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 26. AI IN GENOMICS MARKET BY REGION, 2021
  • FIGURE 27. U.S. AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. CANADA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. MEXICO AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. GERMANY AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. FRANCE AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. UK AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. ITALY AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. SPAIN AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. REST OF EUROPE AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. JAPAN AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. CHINA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. AUSTRALIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. INDIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SOUTH KOREA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. BRAZIL AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SAUDI ARABIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. SOUTH AFRICA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. REST OF LAMEA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP: AI IN GENOMICS MARKET
  • FIGURE 52. TOP PLAYER POSITIONING, 2021
  • FIGURE 53. MICROSOFT CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 54. MICROSOFT CORPORATION.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 55. MICROSOFT CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 56. MICROSOFT CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 59. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022
  • FIGURE 63. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 64. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 65. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 66. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 67. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 68. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 69. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 71. SOPHIA GENETICS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 72. SOPHIA GENETICS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 73. SOPHIA GENETICS: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A11556

The global AI in genomics market was valued at $ 0.34 billion in 2021 and is projected to reach $9.9 billion by 2031, growing at a CAGR of 40.6% from 2022 to 2031.

Genomics is a branch of molecular biology that focuses on the study of the entire genetic material (DNA) of organisms. It involves the analysis of the structure, function, and evolution of genomes, including the identification of genes, their regulatory elements, and how they interact with each other. The field of genomics has grown rapidly over the last few decades due to advances in technology that have made it possible to sequence and analyze DNA more quickly and accurately. With the advent of high-throughput sequencing technologies, it is now possible to sequence entire genomes at a fraction of the cost and time that used to be required earlier. AI in the genomics market refers to the use of artificial intelligence (AI) technologies to support genomic research and applications. With the vast amount of genomic data being generated, AI tools have become increasingly important for analyzing and interpreting this data

AI in Genomics Market - IMG1

The driving factors for AI in the genomics market are advancements in AI technologies, growth in demand for personalized medicine, increase in adoption of genomics in research and healthcare, and rise in investment in AI in genomics. Advancements in AI technologies are the result of the development of machine learning, natural language processing, and deep learning has enabled researchers to analyze and interpret genomic data more accurately and efficiently. As AI technologies continue to improve, their application in genomics is expected to become even more widespread. Personalized medicine involves developing treatment plans tailored to individual patients based on their genomic data. As the demand for personalized medicine continues to grow, the use of AI tools in genomics is becoming increasingly important for identifying genetic variations that may be relevant to a patient's disease or condition. For instance, according to the 2022 report by National Library for Medicine, rheumatoid arthritis and psoriasis as the inflammatory disease, in addition to Alzheimer's disease are diseases having high unmet needs for personalized medicine from the viewpoints of disease mechanisms, diagnostic biomarkers, therapeutic drugs with diagnostic markers and treatment satisfaction.

Furthermore, genomics is becoming an increasingly important tool in both research and healthcare, as it provides important insights into the genetic basis of diseases and other conditions. This is driving the need for more advanced AI tools and technologies to analyze and interpret genomic data. However, factors such as high-cost data quality issues and limited availability of skilled professionals are expected to restrain the growth of AI in the genomics market.

The AI in the genomics market is segmented into offering, technology, application, end-user, and region. Based on offering, the market is segmented into software, services and hardware. By technology, the market is segmented into machine learning and computer vision. By application, the market is segmented into drug discovery & development, precision medicine, diagnostics, and others. By end user, the market is segmented into pharmaceutical and biotech companies, healthcare providers, research centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the AI in genomics market are: Microsoft, IBM, NVIDIA Corporation, Deep Genomics, DATA4CURE, INC, Freenome holdings, Inc, Thermo fisher scientific, Illumina, Inc., Sophia Genetics, and BenevolentAI.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ai in genomics market analysis from 2021 to 2031 to identify the prevailing ai in genomics market opportunities.
  • Market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • An in-depth analysis of the ai in genomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes analysis of the regional as well as global ai in genomics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technology

  • Machine Learning
  • Computer Vision

By Offering

  • Hardware
  • Software
  • Services

By Application

  • Drug Discovery and Development
  • Precision Medicine
  • Diagnostics
  • Others

By End User

  • Pharmaceutical and Biotech Companies
  • Healthcare Providers
  • Research Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

  • IBM Corporation
  • Deep Genomics
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Data4Cure, Inc
  • BenevolentAI
  • Microsoft Corporation
  • NVIDIA Corporation (Mellanox Technologies)
  • Sophia Genetics
  • Freenome Holdings, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Advancements in AI technologies
      • 3.4.1.2. Rising adoption of genomics in research and healthcare
      • 3.4.1.3. Increase ing demand for personalized medicine
    • 3.4.2. Restraints
      • 3.4.2.1. Limited availability of skilled professionals
      • 3.4.2.2. Data quality issues
    • 3.4.3. Opportunities
      • 3.4.3.1. Development of human aware AI
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: AI IN GENOMICS MARKET, BY OFFERING

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Hardware
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Software
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: AI IN GENOMICS MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Machine Learning
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Computer Vision
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: AI IN GENOMICS MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Drug Discovery and Development
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Precision Medicine
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Diagnostics
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: AI IN GENOMICS MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Pharmaceutical and Biotech Companies
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Healthcare Providers
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Research Centers
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: AI IN GENOMICS MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Offering
    • 8.2.3. Market size and forecast, by Technology
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Offering
      • 8.2.6.1.3. Market size and forecast, by Technology
      • 8.2.6.1.4. Market size and forecast, by Application
      • 8.2.6.1.5. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Offering
      • 8.2.6.2.3. Market size and forecast, by Technology
      • 8.2.6.2.4. Market size and forecast, by Application
      • 8.2.6.2.5. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Offering
      • 8.2.6.3.3. Market size and forecast, by Technology
      • 8.2.6.3.4. Market size and forecast, by Application
      • 8.2.6.3.5. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Offering
    • 8.3.3. Market size and forecast, by Technology
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Offering
      • 8.3.6.1.3. Market size and forecast, by Technology
      • 8.3.6.1.4. Market size and forecast, by Application
      • 8.3.6.1.5. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Offering
      • 8.3.6.2.3. Market size and forecast, by Technology
      • 8.3.6.2.4. Market size and forecast, by Application
      • 8.3.6.2.5. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Offering
      • 8.3.6.3.3. Market size and forecast, by Technology
      • 8.3.6.3.4. Market size and forecast, by Application
      • 8.3.6.3.5. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Offering
      • 8.3.6.4.3. Market size and forecast, by Technology
      • 8.3.6.4.4. Market size and forecast, by Application
      • 8.3.6.4.5. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Offering
      • 8.3.6.5.3. Market size and forecast, by Technology
      • 8.3.6.5.4. Market size and forecast, by Application
      • 8.3.6.5.5. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Offering
      • 8.3.6.6.3. Market size and forecast, by Technology
      • 8.3.6.6.4. Market size and forecast, by Application
      • 8.3.6.6.5. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Offering
    • 8.4.3. Market size and forecast, by Technology
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Offering
      • 8.4.6.1.3. Market size and forecast, by Technology
      • 8.4.6.1.4. Market size and forecast, by Application
      • 8.4.6.1.5. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Offering
      • 8.4.6.2.3. Market size and forecast, by Technology
      • 8.4.6.2.4. Market size and forecast, by Application
      • 8.4.6.2.5. Market size and forecast, by End User
      • 8.4.6.3. Australia
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Offering
      • 8.4.6.3.3. Market size and forecast, by Technology
      • 8.4.6.3.4. Market size and forecast, by Application
      • 8.4.6.3.5. Market size and forecast, by End User
      • 8.4.6.4. India
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Offering
      • 8.4.6.4.3. Market size and forecast, by Technology
      • 8.4.6.4.4. Market size and forecast, by Application
      • 8.4.6.4.5. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Offering
      • 8.4.6.5.3. Market size and forecast, by Technology
      • 8.4.6.5.4. Market size and forecast, by Application
      • 8.4.6.5.5. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Offering
      • 8.4.6.6.3. Market size and forecast, by Technology
      • 8.4.6.6.4. Market size and forecast, by Application
      • 8.4.6.6.5. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Offering
    • 8.5.3. Market size and forecast, by Technology
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Offering
      • 8.5.6.1.3. Market size and forecast, by Technology
      • 8.5.6.1.4. Market size and forecast, by Application
      • 8.5.6.1.5. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Offering
      • 8.5.6.2.3. Market size and forecast, by Technology
      • 8.5.6.2.4. Market size and forecast, by Application
      • 8.5.6.2.5. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Offering
      • 8.5.6.3.3. Market size and forecast, by Technology
      • 8.5.6.3.4. Market size and forecast, by Application
      • 8.5.6.3.5. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Offering
      • 8.5.6.4.3. Market size and forecast, by Technology
      • 8.5.6.4.4. Market size and forecast, by Application
      • 8.5.6.4.5. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. Microsoft Corporation
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. IBM Corporation
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. NVIDIA Corporation (Mellanox Technologies)
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
    • 10.3.7. Key strategic moves and developments
  • 10.4. Deep Genomics
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. Data4Cure, Inc
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Freenome Holdings, Inc
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
  • 10.7. Thermo Fisher Scientific Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
  • 10.8. Illumina, Inc.
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
    • 10.8.7. Key strategic moves and developments
  • 10.9. Sophia Genetics
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
  • 10.10. BenevolentAI
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Key strategic moves and developments